HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand-Reference-Cited by-同舟云学术

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand

Published:2016-07-18 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Sukasem Chonlaphat,Jantararoungtong Thawinee,Kuntawong Parnrat,Puangpetch Apichaya,Koomdee Napatrupron,Satapornpong Patompong,Supapsophon Patcharin,Klaewsongkram Jettanong,Rerkpattanapipat Ticha

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Delayed drug hypersensitivity: models of T-cell stimulation;Adam;Br. J. Clin. Pharmacol.,2011

2. Pharmacogenetics of cutaneous adverse drug reactions;Aihara;J. Dermatol.,2011

3. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study;Barvaliya;J. Postgrad. Med.,2011

4. HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese;Cao;Pharmacogenomics,2012

5. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review;Cheng;J. Immunol. Res.,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management;Chinese Medical Journal;2024-09-05

2. Advances in Clinical Pharmacogenomics and Prevention of Severe Cutaneous Adverse Drug Reactions in the Era of Precision Medicine;Personalized Medicine - New Perspectives [Working Title];2024-07-17

3. Elucidating the Mechanisms Underlying Interindividual Differences in the Onset of Adverse Drug Reactions;Biological and Pharmaceutical Bulletin;2024-06-01

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients;BMC Medical Genomics;2024-04-23